Plants inoculated with Pseudomonas putida strain 18/1K and Serratia marcescens strain 62 gave significantly higher yield compared to the control plants. (C) 2013 Elsevier B.V. All rights reserved.”
“A strain producing chitin deacetylase (CDA) was isolated and identified as Rhodococcus erythropolis by morphological characteristics and 16S rDNA analysis, named as R. erythropolis HG05. By Plackett-Burman

and central composite design, CDA production from R. erythropolis HG05 was increased from 58.00 U/mL to 238.89 U/mL. With the crude enzyme from R. erythropolis HG05, the hydrolysate components from colloid chitin were chito-oligosaccharides with polymerization number larger than hexaose. (C) 2013 Elsevier Ltd. All rights reserved.”
“Background and study aims: Paraduodenal pancreatitis is histologically well defined but its epidemiology, natural history, and connection with chronic pancreatitis are not completely understood. The aim of this study was to review the endoscopic Staurosporine solubility dmso and medical management of paraduodenal pancreatitis. Patients and methods: Medical records of all patients with paraduodenal pancreatitis diagnosed by magnetic resonance cholangiopancreatography (MRCP) or endoscopic ultrasonography (EUS) between 1995 and 2010 were retrospectively reviewed. Clinical features, imaging procedures, Selonsertib supplier and treatments were investigated. The primary end point was the rate of clinical success, and the secondary end points were the radiological

or endoscopic improvement, complication rate, and overall survival rate. Results: A total of 51 patients were included in the study (88.2% alcohol abuse; median age 49 years [range 37-70]; 50 men). The most frequent symptoms at presentation

were pain (n=50; 98.0 %) and weight loss (n=36; 70.6 %). Chronic pancreatitis was present in 36 patients (70.6 %), and 45 patients (88.2 %) had cysts. Other findings included stricture of the pancreatic duct (n=37; 72.5 %), common bile duct (n=29; 56.9 %), and duodenum (n=24; 47.1 %). A total of 39 patients underwent initial endoscopic treatment: cystenterostomy (n=20), pancreatic and/or biliary duct drainage (n=19), and/or duodenal dilation (n=6). For the patients with AZD8931 available follow-up (n=41), 24 patients required repeat endoscopy and 9 patients required surgery after the initial endoscopic management. After a median follow-up of 54 months (range 6-156 months), complete clinical success was achieved in 70.7% of patients, and the overall survival rate was 94.1 %. Conclusions: This is the largest series concerning the management of paraduodenal pancreatitis using endotherapy as the first-line intervention. Although repeat endoscopic procedures were required in half of the patients, no severe complication was observed and surgical treatment was ultimately needed in less than 25% of the patients.”
“Development of resorbable elastic composites as an alternative means to apply contractive forces for manipulating craniofacial bones is described herein.